Effects of Danlou Tablet for the treatment of stable angina pectoris: a study protocol of a randomized, double-blind, and placebo-controlled clinical trial

Guang'anmen Hospital,Chinese Academy of Traditiona Chinese medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Conform to the diagnosis of coronary heart disease stable angina pectoris with intermingled phlegm and blood stasis Pattern;
•2. Between the ages of 30 and 75 years;
•3. Volunteer for this event and sign an informed consent form.

•1. Unstable angina pectoris and acute myocardial infarction; other congenital heart disease, valvular disease, severe neurosis caused by chest pain; heart function of grade III or IV; chest pain caused by arrhythmia;
•2. Acute stage of cerebral infarction;
•3. Complicated with heart, brain, liver, kidney, hematopoietic system and other serious primary diseases abnormal renal function;
•4. Acute infection within the last two weeks;
•5. Patients with other serious diseases that require treatment;
•6. Mental disorders or mental retardation that cannot complete the questionnaire;
•7. Pregnant and lactating women;
•8. Tendency to bleed, abnormal of DIC or INR, low platelet;
•9. Patients who did not participate in other clinical trials within 1 month;
•10. Allergic constitution or allergic to test drug ingredient.

发起方

Guang'anmen Hospital,Chinese Academy of Traditiona Chinese medicine